Much of Medtronic’s work in diabetes this year has focused specifically on bringing new technologies to European patients—and its latest purchase continues this trend. The medtech giant snapped up the ...

DUBLIN--(BUSINESS WIRE)--The "Infusion Pumps and Devices: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. Infusion pumps are widely used in hospitals, ...

Canada, Toronto, Dec. 17, 2024 (GLOBE NEWSWIRE) -- An infusion pump is a medical device that delivers fluids, such as medications, nutrients, or blood products, directly into a patient’s bloodstream, ...

Continuous subcutaneous insulin infusion (CSII, or insulin pump therapy) reduces HbA1c levels and hypoglycaemia in patients with type 1 diabetes mellitus (T1DM) compared with multiple daily insulin ...

NEWARK, Del, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The infusion pump market is expected to reach US$ 641.7 million by 2023, putting it on the verge of a significant valuation. The expansion is principally ...

Continuous subcutaneous insulin infusion (CSII) has become an indispensable modality in the management of type 1 diabetes. This therapy employs an insulin pump to deliver both basal and bolus doses, ...

Insulin pumps are portable devices attached to the body that continuously deliver amounts of rapid or short acting insulin via a catheter placed under the skin. They are seen as a better alternative ...

The U.S. Food and Drug Administration has announced a new initiative to address safety problems associated with external infusion pumps, which are often used to deliver fluids, including nutrients and ...